Acceso abiertoPsychologyMedicine
DOI: 10.1093/ijnp/pyx056

Resumen de tlooto

This review explores the current information regarding the afferent modulation of the dopaminergic system and its relevance to major depressive disorder, as well as some of the system-level effects of novel antidepressants such as agomelatine and ketamine.

Resumen

Abstract Anhedonia is considered a core feature of major depressive disorder, and the dopamine system plays a pivotal role in the hedonic deficits described in this disorder. Dopaminergic activity is complex and under the regulation of multiple brain structures, including the ventral subiculum of the hippocampus and the basolateral amygdala. Whereas basic and clinical studies demonstrate deficits of the dopaminergic system in depression, the origin of these deficits likely lies in dysregulation of its regulatory afferent circuits. This review explores the current information regarding the afferent modulation of the dopaminergic system and its relevance to major depressive disorder, as well as some of the system-level effects of novel antidepressants such as agomelatine and ketamine.

Formato de cita

BELUJON, P.; GRACE, A. Dopamine system dysregulation in major depressive disorders. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2017, 20: 1036–1046.